Drugs that contain Rivastigmine
1. Exelon patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US4948807 | SANDOZ | Phenyl carbamates |
Aug, 2012
(11 years ago) | |
| US5602176 | SANDOZ | Phenyl carbamate |
Feb, 2014
(10 years ago) | |
| US6316023 | SANDOZ | TTS containing an antioxidant |
Jan, 2019
(5 years ago) | |
| US6335031 | SANDOZ | TTS containing an antioxidant |
Jan, 2019
(5 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Jun 27, 2016 |
| New Strength(NS) | Aug 31, 2015 |
Market Authorisation Date: 06 July, 2007
Treatment: Treatment of alzheimer's dementia
Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL
How can I launch a generic of EXELON before it's drug patent expiration?
More Information on Dosage
EXELON family patents
